Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having higher antiviral potentials than the drug cand...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Hirofumi, Watashi, Koichi, Saso, Wakana, Shionoya, Kaho, Iwanami, Shoya, Hirokawa, Takatsugu, Shirai, Tsuyoshi, Kanaya, Shigehiko, Ito, Yusuke, Kim, Kwang Su, Nomura, Takao, Suzuki, Tateki, Nishioka, Kazane, Ando, Shuji, Ejima, Keisuke, Koizumi, Yoshiki, Tanaka, Tomohiro, Aoki, Shin, Kuramochi, Kouji, Suzuki, Tadaki, Hashiguchi, Takao, Maenaka, Katsumi, Matano, Tetsuro, Muramatsu, Masamichi, Saijo, Masayuki, Aihara, Kazuyuki, Iwami, Shingo, Takeda, Makoto, McKeating, Jane A., Wakita, Takaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997640/
https://www.ncbi.nlm.nih.gov/pubmed/33817567
http://dx.doi.org/10.1016/j.isci.2021.102367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997640/
https://www.ncbi.nlm.nih.gov/pubmed/33817567
http://dx.doi.org/10.1016/j.isci.2021.102367

Ejemplares similares